Axolotl Biologix
Developer and distributor of human amnion-derived grafts for wound care and tissue repair. Operates an AATB-accredited tissue processing operation, maintains state and federal tissue registrations, publishes peer-reviewed clinical evidence including ongoing randomized controlled trial enrollment, and supplies graft formats for use across hospitals, outpatient clinics and specialty wound centers.
Industries
Nr. of Employees
small (1-50)
Axolotl Biologix
Products
Single-layer amnion graft (multiple sizes)
Sterile human amniotic membrane grafts in multiple sizes for covering and promoting healing of wounds.
Dual-layer amnion graft (multiple sizes)
Dual-layer human amniotic membrane grafts provided in multiple sizes for clinical wound applications.
Single-layer amnion graft (multiple sizes)
Sterile human amniotic membrane grafts in multiple sizes for covering and promoting healing of wounds.
Dual-layer amnion graft (multiple sizes)
Dual-layer human amniotic membrane grafts provided in multiple sizes for clinical wound applications.
Services
Clinical support and training
Provision of technique guides, sales sheets and direct support for clinicians using amnion graft products.
Sales and distribution
Management of sales inquiries, partnership relationships and distribution to healthcare providers across multiple states.
Clinical support and training
Provision of technique guides, sales sheets and direct support for clinicians using amnion graft products.
Sales and distribution
Management of sales inquiries, partnership relationships and distribution to healthcare providers across multiple states.
Expertise Areas
- Wound care and tissue repair
- Tissue processing and biobanking
- Regulatory compliance for human tissue products
- Clinical evidence generation and real-world data
Key Technologies
- Amniotic membrane-based allografts
- Tissue processing and preservation methods
- Biomaterial imaging and characterization (confocal microscopy)
- Electronic Instructions for Use (eIFU) and product documentation